{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:43Z","timestamp":1792791463761,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2021-67015-34316"],"award-info":[{"award-number":["2021-67015-34316"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R21AI194541"],"award-info":[{"award-number":["R21AI194541"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["U01AI72885"],"award-info":[{"award-number":["U01AI72885"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI187756"],"award-info":[{"award-number":["R01AI187756"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001395","name":"Wisconsin Alumni Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT011202"],"award-info":[{"award-number":["R01AT011202"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001664","name":"Leibniz-Gemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["852600"],"award-info":[{"award-number":["852600"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-21-CE18-0050-01"],"award-info":[{"award-number":["ANR-21-CE18-0050-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/12\/RC\/2273\\u2212P2"],"award-info":[{"award-number":["SFI\/12\/RC\/2273\\u2212P2"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/12\/RC\/2273\\u2212P1"],"award-info":[{"award-number":["SFI\/12\/RC\/2273\\u2212P1"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["19\/PSF\/7637"],"award-info":[{"award-number":["19\/PSF\/7637"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mib.2026.102846","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:20:37Z","timestamp":1792718437000},"page":"102846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Next-generation probiotics: beyond lactic acid bacteria to untapped taxa and engineered strains for better health"],"prefix":"10.1016","volume":"94","author":[{"given":"Ruben Vazquez","family":"Uribe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6251-585X","authenticated-orcid":false,"given":"Shrikrishnan","family":"Sankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7525-3131","authenticated-orcid":false,"given":"Luis G","family":"Berm\u00fadez-Humar\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Peter","family":"van Pijkeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary O\u2032Connell","family":"Motherway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-1445","authenticated-orcid":false,"given":"Colin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9400-6918","authenticated-orcid":false,"given":"Sarah","family":"Lebeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2026.102846_bib1","unstructured":"Probiotics Market Size, Share, Growth | Industry Report; 2033 n.d. https:\/\/www.grandviewresearch.com\/industry-analysis\/probiotics-market [Accessed April 22, 2026]."},{"key":"10.1016\/j.mib.2026.102846_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-020-06244-z","article-title":"Efficacy of single-strain probiotics versus multi-strain mixtures: systematic review of strain and disease specificity","volume":"66","author":"McFarland","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mib.2026.102846_sbref2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","article-title":"Engineered commensals for targeted nose-to-brain drug delivery","volume":"188","author":"Shen","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.mib.2026.102846_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13668-020-00313-5","article-title":"Probiotics and the microbiota-gut-brain axis: focus on psychiatry","volume":"9","author":"M\u00f6rkl","year":"2020","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.mib.2026.102846_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41522-020-0127-0","article-title":"Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome","volume":"6","author":"Gilijamse","year":"2020","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.mib.2026.102846_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: a bacterial genus with promising human health applications","volume":"47","author":"Mart\u00edn","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.mib.2026.102846_sbref6","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/s41591-026-04394-7","article-title":"Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial","volume":"32","author":"Mount","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2026.102846_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1556\/1886.2016.00029","article-title":"Insights from 100 years of research with probiotic E. Coli","volume":"6","author":"Wassenaar","year":"2016","journal-title":"Eur J Microbiol Immunol"},{"key":"10.1016\/j.mib.2026.102846_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/1574-6968.12293","article-title":"The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial success","volume":"349","author":"Bull","year":"2013","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.mib.2026.102846_bib10","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/cid\/civ054","article-title":"From yaks to yogurt: the history, development, and current use of probiotics","volume":"60","author":"McFarland","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2026.102846_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.mib.2026.102846_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAD-0017-2017","article-title":"U.S. Regulatory considerations for development of live biotherapeutic products as drugs","volume":"5","author":"Dreher-Lesnick","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mib.2026.102846_bib13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2026.102846_bib14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/10408398.2016.1274877","article-title":"Gene editing and genetic engineering approaches for advanced probiotics: a review","volume":"58","author":"Yadav","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.mib.2026.102846_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9676452","article-title":"The prospects for the therapeutic implications of genetically engineered probiotics","volume":"2020","author":"Mazhar","year":"2020","journal-title":"J Food Qual"},{"key":"10.1016\/j.mib.2026.102846_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12934-022-01799-0","article-title":"Engineered probiotics","volume":"21","author":"Ma","year":"2022","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.mib.2026.102846_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12602-023-10041-1","article-title":"Lactococcus lactis as an interleukin delivery system for prophylaxis and treatment of inflammatory and autoimmune diseases","volume":"16","author":"Campos","year":"2024","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.mib.2026.102846_bib18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-021-01390-x","article-title":"Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease","volume":"27","author":"Scott","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2026.102846_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tem.2024.04.021","article-title":"Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases","volume":"36","author":"Vazquez-Uribe","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.mib.2026.102846_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102846_bib21","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1021\/acssynbio.2c00491","article-title":"Characterization of eight bacterial biosensors for microbial diagnostic and therapeutic applications","volume":"11","author":"Vaaben","year":"2022","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.mib.2026.102846_bib22","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1007\/s00253-016-7557-x","article-title":"Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option","volume":"100","author":"Wang","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.mib.2026.102846_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2110821","article-title":"Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health","volume":"14","author":"Levit","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.mib.2026.102846_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241294134","article-title":"Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study","volume":"15","author":"Schindler","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.mib.2026.102846_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102014","article-title":"Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial","volume":"60","author":"\u00d6hnstedt","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.mib.2026.102846_bib26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s42255-023-00897-6","article-title":"Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial","volume":"5","author":"Vockley","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.mib.2026.102846_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2024.01.005","article-title":"The live biotherapeutic SYNB1353 decreases plasma methionine via directed degradation in animal models and healthy volunteers","volume":"32","author":"Perreault","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2026.102846_bib28","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered E. coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mib.2026.102846_sbref28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.adu8000","article-title":"Controlled colonization of the human gut with a genetically engineered microbial therapeutic","volume":"389","author":"Whitaker","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.mib.2026.102846_othref0010","unstructured":"Aurealis Oy: Phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the AUP1602-C as treatment for non-healing neuro-ischemic DFU. clinicaltrials.gov; 2026"},{"key":"10.1016\/j.mib.2026.102846_bib31","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1128\/AEM.01226-07","article-title":"The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract","volume":"74","author":"Derrien","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.mib.2026.102846_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13099-024-00635-7","article-title":"The influence of Akkermansia muciniphila on intestinal barrier function","volume":"16","author":"Mo","year":"2024","journal-title":"Gut Pathog"},{"key":"10.1016\/j.mib.2026.102846_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2024.12.010","article-title":"Akkermansia muciniphila supplementation in patients with overweight\/obese type 2 diabetes: efficacy depends on its baseline levels in the gut","volume":"37","author":"Zhang","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.mib.2026.102846_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","article-title":"Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice","volume":"6","author":"Yoon","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mib.2026.102846_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1324565","article-title":"Frequently asked questions about the ISAPP postbiotic definition","volume":"14","author":"Vinderola","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mib.2026.102846_bib36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s12257-020-0070-1","article-title":"Genetic biocontainment systems for the safe use of engineered microorganisms","volume":"25","author":"Kim","year":"2020","journal-title":"Biotechnol Bioprocess Eng"},{"key":"10.1016\/j.mib.2026.102846_bib37","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.tibtech.2024.06.011","article-title":"Engineered bacterial therapeutics with material solutions","volume":"42","author":"Dey","year":"2024","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.mib.2026.102846_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1136095","article-title":"Biocontainment strategies for in vivo applications of Saccharomyces boulardii","volume":"11","author":"Hedin","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.mib.2026.102846_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease","volume":"4","author":"Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mib.2026.102846_bib40","first-page":"2024","article-title":"BIOTICS - The case for genetically engineered probiotics and the need for a safe and transparent approach","volume":"35","year":"2024","journal-title":"AgroFOOD Ind Hi Tech"},{"key":"10.1016\/j.mib.2026.102846_bib41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","article-title":"Genetically stable CRISPR-based kill switches for engineered microbes","volume":"13","author":"Rottinghaus","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2026.102846_bib42","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2017.10.033","article-title":"Rational design of evolutionarily stable microbial kill switches","volume":"68","author":"Stirling","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.mib.2026.102846_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202408316","article-title":"PEARL: Protein Eluting Alginate with Recombinant Lactobacilli","volume":"22","author":"Tadimarri","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.mib.2026.102846_sbref42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1126\/science.aec2071","article-title":"Implantable living materials autonomously deliver therapeutics using contained engineered bacteria","volume":"392","author":"Harimoto","year":"2026","journal-title":"Science"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527426001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527426001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:01Z","timestamp":1792788121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527426001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":44,"alternative-id":["S1369527426001402"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2026.102846","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation probiotics: beyond lactic acid bacteria to untapped taxa and engineered strains for better health","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2026.102846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102846"}}